SMPD1 rs121907937: Understanding This Rare Genetic Variant
The rs121907937 variant is a rare genetic change located in the SMPD1 gene. It is recognized as a pathogenic missense mutation associated with Niemann-Pick disease types A and B, which are lysosomal storage disorders.
What each genotype means
Typical risk profile
You do not carry the pathogenic missense variant at this position in the SMPD1 gene. Acid sphingomyelinase deficiency caused by this specific founder mutation is not predicted based on your result. This finding does not rule out being a carrier for other untested variants in the SMPD1 gene.
Carried by greater than 99% of people across most global populations, including non-Ashkenazi Jewish ancestries.
ASMD carrier status
You have one normal allele and one copy of the pathogenic p.Leu304Pro (historically annotated as L302P) variant in the SMPD1 gene. Being a carrier means you generally do not exhibit symptoms of acid sphingomyelinase deficiency (Niemann-Pick disease), but you can pass this variant to your children. Observational studies also note an association between heterozygous SMPD1 pathogenic variants and an increased susceptibility to Parkinson's disease, though absolute risk remains low.
Carried by approximately 1 in 100 individuals of Ashkenazi Jewish ancestry, but extremely rare in other ancestral groups.
Acid sphingomyelinase deficiency
You have two copies of the pathogenic p.Leu304Pro (L302P) variant in the SMPD1 gene, which causes severe reduction or loss of acid sphingomyelinase enzyme function. Biallelic pathogenic variants in SMPD1 are associated with acid sphingomyelinase deficiency (traditionally classified as Niemann-Pick disease type A or B). Genetic counseling and clinical evaluation are typically recommended for individuals with two pathogenic alleles to review implications for health and family planning.
Extremely rare globally, estimated to affect fewer than 1 in 40,000 individuals within Ashkenazi Jewish populations.
What is the rs121907937 Variant?
The rs121907937 variant is a specific change in the DNA sequence of the SMPD1 gene, often referred to as p.Leu304Pro. In genetics, a missense variant means that a single letter change in the DNA code results in the production of a different amino acid during protein synthesis. This specific alteration occurs within the SMPD1 gene, which provides instructions for creating an enzyme called acid sphingomyelinase (ASM). Because this variant is classified as pathogenic, it is known to disrupt the normal function of the resulting protein. Understanding such variants is a key part of clinical genetics, as they help researchers identify the underlying causes of rare inherited conditions. This variant is cataloged in major genetic databases, which track its location and its potential impact on human health based on clinical observations and laboratory studies.
The Role of the SMPD1 Gene
The SMPD1 gene is responsible for producing the acid sphingomyelinase enzyme. This enzyme is essential for the proper function of lysosomes, which are the recycling centers of the cell. Specifically, acid sphingomyelinase breaks down a fatty substance called sphingomyelin into ceramide. When the SMPD1 gene contains pathogenic variants, the body may produce an enzyme that is either non-functional or has significantly reduced activity. Without enough functional enzyme, sphingomyelin begins to accumulate to toxic levels within cells, particularly in the liver, spleen, and nervous system. This accumulation is the hallmark of Niemann-Pick disease types A and B. Type A is typically an early-onset, severe form characterized by neurological involvement, while Type B is generally less severe and often lacks the primary neurological symptoms seen in Type A.
Research and Clinical Associations
Scientific research has established a strong link between pathogenic variants in the SMPD1 gene and Niemann-Pick disease. The rs121907937 variant is specifically documented as a cause of these lysosomal storage disorders. Evidence for this association is derived from clinical genetic testing of individuals diagnosed with the condition. While the association is well-supported in clinical literature, it is important to note that the severity of the disease can vary significantly between individuals, even those with similar genetic profiles. Because Niemann-Pick disease is an autosomal recessive condition, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to manifest the disease. Research continues to explore how different mutations within the SMPD1 gene influence the specific clinical presentation and progression of the disease in affected patients.
Population Frequency
The rs121907937 variant is considered rare in the general global population. However, genetic studies have observed that it occurs with higher frequency in specific ethnic groups, most notably among individuals of Ashkenazi Jewish descent. This phenomenon is often attributed to a founder effect, where a specific genetic variant becomes more common in a population due to the limited number of ancestors who carried the trait. Because of this, genetic screening for SMPD1 variants is sometimes offered to individuals in these communities who are planning to start a family. It is essential to understand that being a carrier of a single copy of this variant does not typically result in the disease, but it does mean there is a possibility of passing the variant to offspring.
Interpreting Your Genetic Information
Information about genetic variants like rs121907937 is intended for educational purposes and should not be used for self-diagnosis or medical decision-making. If you have received results indicating you carry this variant, it is important to consult with a qualified healthcare provider or a genetic counselor. They can provide context based on your personal and family medical history, explain the implications of carrier status, and discuss the availability of diagnostic testing if necessary. Genetic information is complex, and clinical interpretation requires professional expertise to ensure accuracy. Never make changes to your health management or medical care based solely on a report from a genetic testing service. Always seek the guidance of a medical professional who can interpret these findings within the context of your overall health.
How common is this variant?
The rs121907937 variant is rare in the general population but shows a higher prevalence among individuals of Ashkenazi Jewish descent.
Frequently asked questions
What is Niemann-Pick disease?
Niemann-Pick disease is a group of inherited lysosomal storage disorders caused by the body's inability to properly break down fats like sphingomyelin. This leads to the accumulation of these substances in cells, which can cause damage to various organs, including the liver, spleen, and brain.
Does having one copy of the rs121907937 variant mean I have the disease?
Generally, Niemann-Pick disease is an autosomal recessive condition, meaning it usually requires two copies of a pathogenic variant to manifest. Carriers with one copy typically do not show symptoms of the disease, but you should discuss your specific results with a genetic counselor.
Why is this variant more common in Ashkenazi Jewish populations?
This is often due to a founder effect, where a genetic variant becomes more frequent in a specific population because it was present in a small group of ancestors. Over generations, the variant is passed down more frequently within that community.
What should I do if my test shows I am a carrier?
If you are identified as a carrier, you should consult with a genetic counselor or your primary care physician. They can explain what this means for your health and discuss reproductive options or family planning if you are concerned about passing the variant to future children.
Sources & further reading
Educational information only, last refreshed 10/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121907937?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in SMPD1
Pathogenic missense variant (p.Arg498Leu) associated with Niemann-Pick disease types A and B.
Pathogenic substitution (p.Arg498Leu) in SMPD1 associated with Niemann-Pick disease type A/B.
Pathogenic missense variant in SMPD1 (p.Arg498Leu) causing severe infantile Niemann-Pick disease type A in homozygous or compound heterozygous individuals.
Single-nucleotide deletion (c.996delC) leading to acid sphingomyelinase deficiency.
A missense variant (c.1493G>A, p.Arg498Leu) in acid sphingomyelinase conferring carrier status for Niemann-Pick disease types A and B.
Pathogenic missense variant (p.Arg498Leu) causing acid sphingomyelinase deficiency (Niemann-Pick disease type A/B).